Anzeige
Mehr »
Login
Freitag, 03.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Schnelle Produktionsaufnahme: Multi-Tenbagger-Potenzial direkt in Spanien?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
29 Leser
Artikel bewerten:
(0)

European Kidney and Urinary Stone Treatment Devices Market Report 2016 - Research and Markets

DUBLIN, October 11, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "European Market Report for Stone Treatment Devices 2016 - MedCore" report to their offering.

The total market for stone management devices includes ESWL capital equipment, Holmium laser fibers, stone fragment retrieval devices and ureteral stents. These products are often used during endoscopic stone management procedures either in conjunction with ISWL procedures or by themselves.

There are numerous methods for treating and removing kidney and urinary stones. Treatments can be classified as either extracorporeal or endoscopic stone management procedures. Extracorporeal shock wave lithotripsy (ESWL) treatment uses an ultrasound device to fragment the stone until it is small enough to be passed through the urethra.

This is a non-invasive outpatient procedure that generally takes one hour to complete and is performed under local anesthesia. Typically, ESWL is used for small- to medium-sized stones between 1/6 inch and one inch in size. On average, stones re-form in 20% of ESWL patients because fragments are not completely excreted.

Complications associated with ESWL include blocked urine flow from fragments in the urinary tract, bleeding and urinary tract infection. In addition, ESWL is rarely used on cystine kidney stones because these do not break up easily.

Key Topics Covered:

1. Research Methodology

2. Disease Overview
2.1 Basic Anatomy
2.1.1 Human Urinary System
2.2 Urinary Pathology And Disorders
2.3 Patient Demographics

3. Product Assessment
3.1 Product Portfolios
3.1.1 Stone Management
3.2 Clinical Trials

4. Country Profiles
4.1 Introduction
4.1.1.1 Population
4.1.1.2 Median Age
4.1.1.3 GDP Per Capita
4.1.1.4 Price Index

5. Stone Treatment Device Market
5.1 Introduction
5.2 Market Overview
5.3 Market Analysis And Forecast
5.4 Drivers And Limiters
5.5 Competitive Market Share Analysis

Companies Mentioned

  • Ace Medical Devices
  • Ackermann
  • Aspide
  • Astora
  • B. Braun
  • Bactiguard
  • Best Medical
  • BioDerm
  • Biolitec
  • Boston Scientific
  • C. R. Bard
  • CL Medical
  • Caldera Medical
  • Coloplast
  • Convergent Laser Technologies
  • Cook Medical
  • Cousin Biotech
  • Covidien
  • EDAP TMS
  • Eckert & Ziegler BEBIG
  • Electro Medical Systems
  • Elekta
  • Ethicon
  • GE Healthcare (Oncura)
  • Karl Storz
  • Neomedic International
  • Olympus
  • PercSys
  • Poiesis Medical
  • Promedon
  • Quanta Systems
  • ROCAMED
  • Richard Wolf
  • Siemens
  • Stryker

For more information about this report visit http://www.researchandmarkets.com/research/bmmqg4/european_market

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2016 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.